Combination thymosin-alpha 1 and interferon-alpha 2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey

Saruc M., Yuceyar H., Kucukmetin N., Demir M., Kandiloglu A.

HEPATO-GASTROENTEROLOGY, vol.49, no.45, pp.798-802, 2002 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 49 Issue: 45
  • Publication Date: 2002
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.798-802
  • Acibadem Mehmet Ali Aydinlar University Affiliated: Yes


Background/Aims: The most prevalent type of chronic hepatitis B in Turkey is anti-HBe-positive. No consistently effective therapy is yet available for the treatment of these patients. The aim of this study was to assess the efficacy and safety of interferon-alpha and thymosin-alpha(1) combination in the treatment of naive anti-HBe-positive and HBV DNA-positive chronic hepatitis B patients.